Overall rank by patents
#45,092
of 49,997 tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Beijing Bio-targeting Therapeutics Technology Inc.
USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Beijing ranks #45,092 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.
- #45,092
- of 49,997 US assignees by volume
- 29th percentile
- by Innovation Score (29.0/100)
- 4.0
- avg claims per patent
- -33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R45092 · Foreign Corporation #45,092 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #45,092/49,997
- PHOTO-FINISH Beco Holding
- CPC-NARROW C12N · 4 areas
- INNOV-THIN 29.0/100
- CLAIMS-SPARSE 4.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Beco Holding Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Innovation-score neighbourhood around Beijing
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Beijing Bio-targetin… · this assignee 29
Beijing Bio-targetin… · this assignee
29 score
- Nevis Industries · near 29
Nevis Industries · near
29 score
- Nvidia Technology UK · near 29
Nvidia Technology UK · near
29 score
- Orlucent · near 29
Orlucent · near
29 score
- Unitract Syringe PTY · near 29
Unitract Syringe PTY · near
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Beijing's Innovation Score is 29.0/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Where Beijing's grants concentrate
Beijing Bio-targeting Therapeutics Technology Inc. is a focused PatentsView assignee: 4 CPC subclasses with 80% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2016. By volume, Beijing sits between Beco Holding Limited and Beijing Hengxiang Hongye Foundation Reinforcement Technology Co., Ltd..
Beijing's three-year grant acceleration
Beijing Bio-targeting Therapeutics Technology Inc. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Beijing's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Beco Holding
Beco Holding Limited
5 patents
- Becoflex
Becoflex
5 patents
- Beijing Aerospace…
Beijing Aerospace Petrochemical Technology AND Equipment Engineering Corporation Limited
5 patents
- Beijing Beishute…
Beijing Beishute Maternity & Child Articles Co., Ltd
5 patents
- Beijing Bytedance…
Beijing Bytedance Technology Co., Ltd.
5 patents
- Beijing Deepcool…
Beijing Deepcool Industries Co., Ltd.
5 patents
- Beijing Deephi In…
Beijing Deephi Intelligent Technology Co., Ltd.
5 patents
- Beijing Hengxiang…
Beijing Hengxiang Hongye Foundation Reinforcement Technology Co., Ltd.
5 patents
- Beijing Bio-targe… ◀
Beijing Bio-targeting Therapeutics Technology Inc.
5 patents
What this shows Beijing holds 5 patents at rank #45,066, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Beijing
By rank, the assignees closest to #45,066 in granted patent volume.
- Beco Holding Limited #45,062 · 5 patents
- Becoflex #45,063 · 5 patents
- Beijing Aerospace Petrochemical Technology AND Equipment Engineering Corporation Limited #45,064 · 5 patents
- Beijing Beishute Maternity & Child Articles Co., Ltd #45,065 · 5 patents
- Beijing Bytedance Technology Co., Ltd. #45,067 · 5 patents
- Beijing Deepcool Industries Co., Ltd. #45,068 · 5 patents
- Beijing Deephi Intelligent Technology Co., Ltd. #45,069 · 5 patents
- Beijing Hengxiang Hongye Foundation Reinforcement Technology Co., Ltd. #45,070 · 5 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Beijing's primary technology class.
- Monsanto Technology LLC 1,335 in class
- The Regents of the University of California 1,161 in class
- Novozymes A/S 656 in class
- Immatics Biotechnologies GmbH 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President and Fellows of Harvard College 594 in class
- Massachusetts Institute of Technology 541 in class
- The Trustees of the University of Pennsylvania 537 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Beijing, neither rank-band nor same-CPC leaders (those blocks stay above).
Similar innovation score
Nearest assignees by Innovation Score (29 here).
Beijing's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 29th percentile higher than 29% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 20.0% |
| 2018 | 1 | 20.0% |
| 2019 | 1 | 20.0% |
| 2022 | 2 | 40.0% |
Which technologies does Beijing Bio-targeting Therapeutics Technology Inc. patent most?
Top 4 of 4 technology areas
What to do with this data
Beijing Bio-targeting Therapeutics Technology Inc.'s patent record in context - here's where to go next.
- Beijing Bio-targeting Therapeutics Technology Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 80% of its portfolio - see every assignee active in that class. Explore C12N
- Ranked #45,092 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Beijing Bio-targeting Therapeutics Technology Inc. against Beco Holding Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.